Tango Therapeutics, Inc. (TNGX)
19.77
-0.03
(-0.15%)
USD |
NASDAQ |
Apr 08, 12:57
Tango Therapeutics Cash from Investing (TTM) : -40.86M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Revolution Medicines, Inc. | 118.06M |
| Kodiak Sciences, Inc. | -0.506M |
| Recursion Pharmaceuticals, Inc. | -16.87M |
| AbbVie, Inc. | -6.643B |
| Terns Pharmaceuticals, Inc. | -298.04M |